← Gildan Activewear overview

Gildan Activewear vs Kering SA: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Gildan Activewear Inc. (GIL)

Q3 2026
▼3

Gildan hit by channel-stuffing fraud claims and mounting lawsuits

  • Short-seller channel-stuffing report Jehoshaphat Research accused Gildan of stuffing the sales channel — pushing extra product to distributors to make revenue look stronger than real demand — and hiding receivables off its books. Shares fell about 18.7% in a day, wiping out roughly $2.15 billion in value.

    This is the core event driving GIL's price and everything else this period.

  • Securities fraud investigations multiply Several US law firms (Bleichmar Fonti & Auld, Rosen, Hagens Berman, Frank R. Cruz) opened investigations and are preparing class actions claiming Gildan misled investors. These are still investigations, not proven findings, but they keep legal risk and uncertainty hanging over the stock.

    Legal escalation is the main new development after the initial drop.

  • Accounting credibility questioned The report claims years of weak underlying growth were masked by financial engineering, and that nearly half of receivables were moved off the balance sheet. If true, past profits and sales may have been overstated, which could force restatements and undermine trust in management.

    Explains why the allegations matter beyond a one-day price drop.

  • Allegations unproven; company response pending All of this rests on a short seller's report and law firm investigations — no court has found wrongdoing, and short sellers profit if the stock falls, so their claims deserve scrutiny. Gildan has not yet been shown here to have answered the allegations, leaving the picture genuinely unresolved.

    Gives the fair counterweight readers need before acting on the bearish news.

July 2026
▼3

Gildan hit by channel-stuffing fraud claims and mounting lawsuits

  • Short-seller channel-stuffing report Jehoshaphat Research accused Gildan of stuffing the sales channel — pushing extra product to distributors to make revenue look stronger than real demand — and hiding receivables off its books. Shares fell about 18.7% in a day, wiping out roughly $2.15 billion in value.

    This is the core event driving GIL's price and everything else this period.

  • Securities fraud investigations multiply Several US law firms (Bleichmar Fonti & Auld, Rosen, Hagens Berman, Frank R. Cruz) opened investigations and are preparing class actions claiming Gildan misled investors. These are still investigations, not proven findings, but they keep legal risk and uncertainty hanging over the stock.

    Legal escalation is the main new development after the initial drop.

  • Accounting credibility questioned The report claims years of weak underlying growth were masked by financial engineering, and that nearly half of receivables were moved off the balance sheet. If true, past profits and sales may have been overstated, which could force restatements and undermine trust in management.

    Explains why the allegations matter beyond a one-day price drop.

  • Allegations unproven; company response pending All of this rests on a short seller's report and law firm investigations — no court has found wrongdoing, and short sellers profit if the stock falls, so their claims deserve scrutiny. Gildan has not yet been shown here to have answered the allegations, leaving the picture genuinely unresolved.

    Gives the fair counterweight readers need before acting on the bearish news.

Latest
▼3

Gildan hit by channel-stuffing fraud claims and mounting lawsuits

  • Short-seller channel-stuffing report Jehoshaphat Research accused Gildan of stuffing the sales channel — pushing extra product to distributors to make revenue look stronger than real demand — and hiding receivables off its books. Shares fell about 18.7% in a day, wiping out roughly $2.15 billion in value.

    This is the core event driving GIL's price and everything else this period.

  • Securities fraud investigations multiply Several US law firms (Bleichmar Fonti & Auld, Rosen, Hagens Berman, Frank R. Cruz) opened investigations and are preparing class actions claiming Gildan misled investors. These are still investigations, not proven findings, but they keep legal risk and uncertainty hanging over the stock.

    Legal escalation is the main new development after the initial drop.

  • Accounting credibility questioned The report claims years of weak underlying growth were masked by financial engineering, and that nearly half of receivables were moved off the balance sheet. If true, past profits and sales may have been overstated, which could force restatements and undermine trust in management.

    Explains why the allegations matter beyond a one-day price drop.

  • Allegations unproven; company response pending All of this rests on a short seller's report and law firm investigations — no court has found wrongdoing, and short sellers profit if the stock falls, so their claims deserve scrutiny. Gildan has not yet been shown here to have answered the allegations, leaving the picture genuinely unresolved.

    Gives the fair counterweight readers need before acting on the bearish news.

Q2 2026
▼3

Short Seller's Channel Stuffing Claims Trigger Investigations and 18% Drop

  • Short seller report alleges channel stuffing and hidden weak growth On June 16, Jehoshaphat Research accused Gildan of inflating sales by pushing extra product to customers at quarter-ends and hiding weak underlying growth. The stock fell about 18% in one day, wiping out $2.15 billion in market value. If true, past profits were borrowed from the future, so investors now doubt how strong the business really is.

    This is the core new event that answers why GIL is moving and sets up all later investigations.

  • Multiple law firms launch securities investigations At least seven law firms, including Holzer & Holzer, Siskinds, Bronstein Gewirtz & Grossman, Hagens Berman, BFA Law, Pomerantz, and Rosen, have opened investigations into possible securities fraud or class actions. These probes raise the risk of lawsuits, fines, and management distraction, which weighs on the stock and makes investors more cautious.

    The wave of investigations is a new, separate force pushing GIL down and increasing uncertainty.

  • Allegations question true organic growth and accounting The short report claims Gildan's organic growth has actually been negative for years and that the company used financial engineering, like moving receivables off the balance sheet, to make results look better. If real growth is weaker than reported, the stock's value based on steady growth is too high, so investors are repricing it lower.

    This explains the fundamental doubt behind the price drop, not just the legal noise.

June 2026
▼3

Short Seller's Channel Stuffing Claims Trigger Investigations and 18% Drop

  • Short seller report alleges channel stuffing and hidden weak growth On June 16, Jehoshaphat Research accused Gildan of inflating sales by pushing extra product to customers at quarter-ends and hiding weak underlying growth. The stock fell about 18% in one day, wiping out $2.15 billion in market value. If true, past profits were borrowed from the future, so investors now doubt how strong the business really is.

    This is the core new event that answers why GIL is moving and sets up all later investigations.

  • Multiple law firms launch securities investigations At least seven law firms, including Holzer & Holzer, Siskinds, Bronstein Gewirtz & Grossman, Hagens Berman, BFA Law, Pomerantz, and Rosen, have opened investigations into possible securities fraud or class actions. These probes raise the risk of lawsuits, fines, and management distraction, which weighs on the stock and makes investors more cautious.

    The wave of investigations is a new, separate force pushing GIL down and increasing uncertainty.

  • Allegations question true organic growth and accounting The short report claims Gildan's organic growth has actually been negative for years and that the company used financial engineering, like moving receivables off the balance sheet, to make results look better. If real growth is weaker than reported, the stock's value based on steady growth is too high, so investors are repricing it lower.

    This explains the fundamental doubt behind the price drop, not just the legal noise.

▼3

Short Seller's Channel Stuffing Claims Trigger Investigations and 18% Drop

  • Short seller report alleges channel stuffing and hidden weak growth On June 16, Jehoshaphat Research accused Gildan of inflating sales by pushing extra product to customers at quarter-ends and hiding weak underlying growth. The stock fell about 18% in one day, wiping out $2.15 billion in market value. If true, past profits were borrowed from the future, so investors now doubt how strong the business really is.

    This is the core new event that answers why GIL is moving and sets up all later investigations.

  • Multiple law firms launch securities investigations At least seven law firms, including Holzer & Holzer, Siskinds, Bronstein Gewirtz & Grossman, Hagens Berman, BFA Law, Pomerantz, and Rosen, have opened investigations into possible securities fraud or class actions. These probes raise the risk of lawsuits, fines, and management distraction, which weighs on the stock and makes investors more cautious.

    The wave of investigations is a new, separate force pushing GIL down and increasing uncertainty.

  • Allegations question true organic growth and accounting The short report claims Gildan's organic growth has actually been negative for years and that the company used financial engineering, like moving receivables off the balance sheet, to make results look better. If real growth is weaker than reported, the stock's value based on steady growth is too high, so investors are repricing it lower.

    This explains the fundamental doubt behind the price drop, not just the legal noise.

Kering SA (KER.PA)

Q3 2026
▲2▼2

Gucci Stabilizes but China and Legal Risks Weigh on Kering

  • Gucci turnaround gains traction Gucci's Q2 organic sales fell only 2%, leather goods returned to growth, and shares jumped 15–17%, prompting upgrades such as HSBC's €340 target. This signals the turnaround is working.

    It explains the main positive force behind Kering's stock during the quarter.

  • Financial health improves and jewelry grows H1 revenue rose 1%, operating margin improved to 12.8%, net debt fell €4.7bn to €3.3bn, and jewelry grew 22%, offering a second growth engine beyond Gucci.

    It highlights the improving financial picture and diversification that supported the stock.

  • China slump and store closures pressure sales China's luxury slump, with Gucci, Bottega Veneta and Balenciaga down double digits, pressures sales. Kering has closed 217+ stores in 18 months, confirming weak demand.

    It captures the key negative force from weak demand in a major market.

  • Legal probe and brand equity risks Kering faces a tariff-refund class-action probe and a $400M Gucci Beauty exit cost. Gucci's 20–30% price cuts may lift volumes but risk brand equity, while Goldman rates Kering Neutral.

    It shows the legal and strategic risks that weighed on sentiment.

September 2026
▼3

Kering's China Slump and Store Closures Keep Recovery Out of Reach

  • China luxury demand slumps on wealth tax crackdown China's campaign to tax offshore wealth is hitting rich shoppers hard. Sales at the 25 biggest luxury labels in China fell over 10% in July, with Gucci, Bottega Veneta and Balenciaga all down double digits. Since China is luxury's biggest growth market, this directly pressures Kering's sales and share price.

    China weakness is the single biggest force dragging Kering's revenue and stock down this period.

  • Kering keeps closing stores as sales density lags Kering has shut at least 217 stores in 18 months, including 84 net closures in the first half of 2026, and targets 100 for the full year. Closing stores cuts costs but also confirms weak demand and shrinking revenue, which weighs on the stock.

    Store closures show management reacting to weak demand, a core driver of the investment case.

  • Gucci price cuts may lift sales but risk brand equity Bernstein says Gucci's 20-30% price cuts could support near-term sales, but warn they may weaken the brand's long-term pricing power. The cuts are a double-edged sword: they help volumes now while raising questions about Gucci's positioning.

    Pricing strategy is a key lever for Kering's turnaround and cuts both ways for the stock.

  • Goldman starts Kering at Neutral, not a top pick Goldman Sachs began covering European luxury and rated only Richemont, LVMH, Moncler and Prada as Buys, leaving Kering at Neutral. That signals Kering is not seen as a sector winner, which can keep some investors on the sidelines.

    Analyst ratings influence investor sentiment and fund flows into the stock.

Latest
▼3

Kering's China Slump and Store Closures Keep Recovery Out of Reach

  • China luxury demand slumps on wealth tax crackdown China's campaign to tax offshore wealth is hitting rich shoppers hard. Sales at the 25 biggest luxury labels in China fell over 10% in July, with Gucci, Bottega Veneta and Balenciaga all down double digits. Since China is luxury's biggest growth market, this directly pressures Kering's sales and share price.

    China weakness is the single biggest force dragging Kering's revenue and stock down this period.

  • Kering keeps closing stores as sales density lags Kering has shut at least 217 stores in 18 months, including 84 net closures in the first half of 2026, and targets 100 for the full year. Closing stores cuts costs but also confirms weak demand and shrinking revenue, which weighs on the stock.

    Store closures show management reacting to weak demand, a core driver of the investment case.

  • Gucci price cuts may lift sales but risk brand equity Bernstein says Gucci's 20-30% price cuts could support near-term sales, but warn they may weaken the brand's long-term pricing power. The cuts are a double-edged sword: they help volumes now while raising questions about Gucci's positioning.

    Pricing strategy is a key lever for Kering's turnaround and cuts both ways for the stock.

  • Goldman starts Kering at Neutral, not a top pick Goldman Sachs began covering European luxury and rated only Richemont, LVMH, Moncler and Prada as Buys, leaving Kering at Neutral. That signals Kering is not seen as a sector winner, which can keep some investors on the sidelines.

    Analyst ratings influence investor sentiment and fund flows into the stock.

July 2026
▲3▼1

Kering's Gucci turnaround gains traction, but tariff probe and $400M exit cost linger

  • Gucci turnaround drives 15%+ share surge Kering shares jumped about 15-17% after Q2 results showed Gucci's sales fell only 2% organically, far less than feared, and leather goods returned to growth. Analysts upgraded the stock, with HSBC raising its target to €340. This is the main force pushing KER.PA up.

    This is the biggest new event of the period and directly explains the sharp share price move.

  • First-half return to growth and debt cut Kering reported H1 2026 revenue up 1% and Q2 up 2%, with operating margin improving to 12.8%. Net debt fell by €4.7 billion to €3.3 billion, helped by €2.6 billion free cash flow. This supports the recovery story and gives the company more financial room.

    These results underpin the positive share move and show the turnaround is more than just Gucci.

  • Jewelry becomes a growth engine Kering's jewelry sales rose 22% in Q1, the fastest among its businesses, as consumers shift toward jewelry amid high gold prices and fashion fatigue. This trend, seen across the luxury sector, gives Kering a valuable second growth driver beyond Gucci.

    It highlights a structural positive for Kering's revenue mix that investors are rewarding.

  • Tariff refund probe and $400M Gucci Beauty exit cost Kering faces a class-action investigation over whether it kept tariff-related price hikes after tariffs were struck down, a potential legal and reputational risk. It also paid $400 million to end the Gucci beauty license early, a cash cost that partly offsets the positive results.

    These are real counterweights that could weigh on the stock and are new this period.

▲3▼1

Kering's Gucci turnaround gains traction, but tariff probe and $400M exit cost linger

  • Gucci turnaround drives 15%+ share surge Kering shares jumped about 15-17% after Q2 results showed Gucci's sales fell only 2% organically, far less than feared, and leather goods returned to growth. Analysts upgraded the stock, with HSBC raising its target to €340. This is the main force pushing KER.PA up.

    This is the biggest new event of the period and directly explains the sharp share price move.

  • First-half return to growth and debt cut Kering reported H1 2026 revenue up 1% and Q2 up 2%, with operating margin improving to 12.8%. Net debt fell by €4.7 billion to €3.3 billion, helped by €2.6 billion free cash flow. This supports the recovery story and gives the company more financial room.

    These results underpin the positive share move and show the turnaround is more than just Gucci.

  • Jewelry becomes a growth engine Kering's jewelry sales rose 22% in Q1, the fastest among its businesses, as consumers shift toward jewelry amid high gold prices and fashion fatigue. This trend, seen across the luxury sector, gives Kering a valuable second growth driver beyond Gucci.

    It highlights a structural positive for Kering's revenue mix that investors are rewarding.

  • Tariff refund probe and $400M Gucci Beauty exit cost Kering faces a class-action investigation over whether it kept tariff-related price hikes after tariffs were struck down, a potential legal and reputational risk. It also paid $400 million to end the Gucci beauty license early, a cash cost that partly offsets the positive results.

    These are real counterweights that could weigh on the stock and are new this period.